-=FMC Corp (FMC) reported earnings on Tue 2 Nov 21 (a/h)

 

FMC Corp beats by $0.11, beats on revs; guides Q4 EPS in-line, revs in-line

• Reports Q3 (Sep) earnings of $1.43 per share, excluding non-recurring items, $0.11 better than the S&P Capital IQ Consensus of $1.32; revenues rose 9.7% year/year to $1.19 bln vs the $1.17 bln S&P Capital IQ Consensus.
• Co issues in-line guidance for Q4, sees EPS of $1.80-2.20, excluding non-recurring items, vs. $2.08 S&P Capital IQ Consensus; sees Q4 revs of $1.27 to $1.47 billion vs. $1.37 bln S&P Capital IQ Consensus.
• Mark Douglas, FMC president and chief executive officer, said, "FMC delivered a strong quarter driven by robust product demand. Our operations and procurement teams overcame supply chain and logistics challenges that have impacted many industries. Adjusted EBITDA momentum not only reflects volume growth, but also our focus on increasing prices, continued cost discipline, and a shift in timing of some cost headwinds. In addition, we are seeing significant contribution to growth this year from new product launches and from FMC's Plant Health business, reflecting the strength of our innovation capabilities and world-class R&D pipeline."